Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Roberta Venturella, Julie Perry, Silvia Vannuccini, Viatcheslav Rakov et al.
Citations
4 citations
Journal
Fertility and Sterility
Topics
Endometriosis Research and Treatment
Field-Weighted Citation Impact (FWCI)
6.79
article
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Roberta Venturella, Julie Perry, Silvia Vannuccini, Viatcheslav Rakov, William H. Catherino, Malcolm G. Munro, Ayman Al-Hendy, Elizabeth A. Stewart, Souhil Zaim, Rui Wu, Nadia Bouzegaou
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Fertility and SterilityVol. 124(3)
Institutions
Mayo Clinic (US), WinnMed (US), Magna Graecia University (IT), Sumitomo Dainippon Pharma (United States) (US)